Masayuki Sugimoto Selected Research

Endoleak

4/2023	The Association Between the D-dimer Level at 1 Year After EVAR and Sac Diameter Change in Patients With Persistent Type 2 Endoleak.
4/2022	New Morphological Factor for Predicting Late Proximal Type I Endoleak after Endovascular Aneurysm Repair.
1/2021	The association between perioperative embolization of hypogastric arteries and type II endoleaks after endovascular aortic aneurysm repair.
11/2020	Early and midterm outcomes of celiac artery coverage during thoracic endovascular aortic repair.
7/2020	Aneurysm Sac Thrombus Volume Predicts Aneurysm Expansion with Type II Endoleak After Endovascular Aneurysm Repair.
2/2017	The Relationship between Temporal Changes in Proximal Neck Angulation and Stent-Graft Migration after Endovascular Abdominal Aortic Aneurysm Repair.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Masayuki Sugimoto Research Topics

Disease

7	Aneurysm (Aneurysms) 04/2023 - 10/2012
6	Endoleak 04/2023 - 02/2017
5	Neoplasms (Cancer) 01/2024 - 04/2004
5	Obesity 12/2020 - 12/2008
5	Abdominal Aortic Aneurysm 11/2019 - 01/2015
4	Thrombosis (Thrombus) 02/2024 - 07/2020
3	Chronic Limb-Threatening Ischemia 01/2022 - 02/2015
3	Stroke (Strokes) 08/2017 - 01/2015
3	Insulin Resistance 08/2016 - 12/2008
3	Body Weight (Weight, Body) 03/2010 - 12/2008
3	Metabolic Syndrome (Dysmetabolic Syndrome X) 03/2010 - 12/2008
3	Inflammation (Inflammations) 03/2010 - 12/2008
2	Aortic Dissection 02/2024 - 11/2020
2	Thoracic Aortic Aneurysm 02/2024 - 12/2022
2	Iliac Aneurysm 11/2022 - 07/2018
2	Rupture 07/2021 - 11/2020
2	Atherosclerosis 01/2016 - 06/2009
2	Type 2 Diabetes Mellitus (MODY) 02/2015 - 12/2008
2	Hyperplasia 01/2009 - 10/2005
1	Embolism (Embolus) 02/2024
1	Spinal Cord Injuries (Spinal Cord Injury) 02/2024
1	Venous Thrombosis (Deep-Vein Thrombosis) 01/2024
1	Aortic Aneurysm (Aneurysm, Aortic) 12/2022
1	Malnutrition (Nutritional Deficiencies) 01/2022
1	Sarcopenia 01/2022
1	Chronic Renal Insufficiency 07/2021
1	Spinal Cord Ischemia 01/2021
1	Liver Cirrhosis (Hepatic Cirrhosis) 12/2020
1	Fibrosis (Cirrhosis) 12/2020
1	Carcinogenesis 10/2020
1	Liver Neoplasms (Liver Cancer) 10/2020
1	Varicose Veins (Varicose Vein) 07/2020
1	Hypertrophy 03/2018
1	Gout 01/2018
1	Obstructive Lung Diseases (Obstructive Lung Disease) 08/2017
1	Hypertension (High Blood Pressure) 08/2017
1	Hypercholesterolemia 07/2016
1	Paraplegia (Spastic Paraplegia) 07/2016
1	Aortic Arch Aneurysm 07/2016
1	Fatty Liver 01/2016
1	Dyslipidemias (Dyslipidemia) 01/2016
1	Ischemia 02/2015
1	Hemorrhage 01/2015
1	Hyperlipidemias (Hyperlipidemia) 01/2015
1	Delirium 01/2015
1	Compartment Syndromes 10/2012
1	Sepsis (Septicemia) 10/2012

Drug/Important Bio-Agent (IBA)

3	phosphatidylcholine-ceramide phosphocholine transferaseIBA 12/2020 - 01/2016
3	Glucose (Dextrose)FDA LinkGeneric 02/2015 - 12/2008
2	fibrin fragment D (D-dimer)IBA 01/2024 - 04/2023
2	Indicators and Reagents (Reagents)IBA 01/2022 - 04/2004
2	ZincIBA 01/2022 - 02/2020
2	LipidsIBA 12/2020 - 03/2010
2	SphingomyelinsIBA 12/2020 - 01/2016
2	CC ChemokinesIBA 03/2010 - 12/2008
2	propagermanium (Ge 132)IBA 03/2010 - 12/2008
2	Triglycerides (Triacylglycerol)IBA 03/2010 - 12/2008
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2009 - 10/2005
2	rho-Associated KinasesIBA 01/2009 - 10/2005
1	Choline (Choline Chloride)IBA 12/2020
1	Carbon Tetrachloride (Tetrachloromethane)IBA 12/2020
1	Amino Acids FDA Link 12/2020
1	sphingosine 1-phosphate (sphingosine-1-phosphate)IBA 12/2020
1	Phosphotransferases (Kinase)IBA 10/2020
1	Reactive Oxygen Species (Oxygen Radicals)IBA 10/2020
1	Colchicine FDA LinkGeneric 01/2018
1	Uric Acid (Urate)IBA 01/2018
1	Febuxostat FDA Link 01/2018
1	CreatinineIBA 08/2017
1	oxidized low density lipoproteinIBA 07/2016
1	LDL CholesterolIBA 07/2016
1	Atorvastatin (Lipitor)FDA Link 07/2016
1	alirocumabIBA 07/2016
1	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 01/2016
1	Apolipoprotein A-I (Apolipoprotein A1)IBA 01/2016
1	Cholesterol Ester Transfer ProteinsIBA 01/2016
1	EnzymesIBA 01/2016
1	SphingolipidsIBA 01/2016
1	HDL CholesterolIBA 01/2016
1	CeramidesIBA 01/2016
1	ApolipoproteinsIBA 01/2016
1	Lipoproteins (Lipoprotein)IBA 01/2016
1	Metformin (Glucophage)FDA LinkGeneric 02/2015
1	NitrogenIBA 01/2015
1	Urea (Carbamide)FDA LinkGeneric 01/2015
1	CholesterolIBA 01/2015
1	Anti-Bacterial Agents (Antibiotics)IBA 10/2012

Therapy/Procedure

14	Endovascular Aneurysm Repair 02/2024 - 01/2015
1	Drug Therapy (Chemotherapy) 01/2024
1	Aftercare (After-Treatment) 11/2022
1	Renal Replacement Therapy (Therapies, Renal Replacement) 07/2021
1	Laser Therapy (Surgery, Laser) 07/2020
1	Sclerotherapy 07/2020
1	Prostheses and Implants (Prosthesis) 07/2018
1	Hip Replacement Arthroplasty (Total Hip Replacement) 03/2018
1	Therapeutics 01/2018
1	Renal Dialysis (Hemodialysis) 08/2017
1	Stents 02/2017
1	Length of Stay 01/2015
1	Fasciotomy 10/2012